
Regnum Corp.
RGMPOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2295
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Regnum Corp.(RGMP)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · RGMP · 截至 Jun 9, 2026
关键指标
探索 Regnum Corp. 数据
rgmp stock data · financials财务快照
完整财报FY 2022Revenue$0.00
202020212022
regnum corp. revenue · rgmp revenue 2022FY 2022Net Income-$781000.00▼ 189.26% YoY
202020212022
regnum corp. net income · rgmp profit 2022FY 2022EPS$-0.03▼ 193.10% YoY
202020212022
rgmp eps · regnum corp. earnings per share 2022竞争对手与同行
rgmp competitors#TickerCompanyPriceChangeMkt Cap
#1Regnum Corp.
$0.00+0.00%$2,295#2Ampio Pharmaceuticals, Inc.
$0.18+0.00%$207,884#3Bioasis Technologies Inc.
$0.00+0.00%$7,941#4Golden Developing Solutions, Inc.
$0.00+0.00%$14,135#5Lombard Medical, Inc.
$0.00+0.00%$2,795#6GB Sciences, Inc.
$0.00+33.33%$162,828股票表现
完整历史1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y-99.98%
关于 Regnum Corp.
Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functi…
what is regnum corp. · rgmp stock overview · regnum corp. company profile · who is regnum corp. ceo · rgmp OTC · regnum corp. headquarters · regnum corp. business segments
关于股票概览与关键数据
Regnum Corp.(RGMP)是 Biotechnology 行业的 Healthcare 类公司,于 May 29, 2019 在 OTC 上市。截至最近交易日,RGMP 股价为 $0.00,市值约为 $2,295。过去12个月累计回报 +0.00%,年初至今回报 +0.00%。
2022 财年 Regnum Corp. 营收 —。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。
常见问题
截至最近一个交易日,Regnum Corp.(RGMP)股价为 $0.00,在 OTC 上市,52周区间为 $0.00 – $0.00。
RGMP 最新股价RGMP quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议